Literature DB >> 8571283

[Neutropenia during treatment with fusidic acid: analysis of 5 cases].

T Vial1, D Gontier, L Pinède, P Cance, C Pofilet, J C Evreux.   

Abstract

Two cases of moderate neutropenia and 3 cases of severe neutropenia in the course of fusidic acid treatment for sepsis related to a hip prothesis or septic osteitis are reported. Neutropenia was always observed following routine blood cell count, after a mean of 21 days' treatment (16 to 27 days). Moderate fever was observed only once, in a patient with profound neutropenia. A complete recovery of blood cell count was noted in all cases, 5 to 9 days upon discontinuation of fusidic acid. A sternal bone-marrow aspiration was performed in 4 cases, showing normocellularity or hypercellularity in two cases, and moderate hypoplasia of granulocytic cells. The respective roles of other treatments are discussed. Overall, these five cases suggest that reversible granulocytopenia can be caused by protracted treatment with fusidic acid. Although nine different associated drugs could also have been involved in four patients, the causal relationship was less suggestive for three of them due to chronological events. In other cases, the drugs never or very rarely caused neutropenia. Finally, the possibility of vancomycin-induced neutropenia cannot be excluded in one case.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8571283

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  1 in total

1.  Bicytopenia in a 15-Year-Old Adolescent: A Rare Side Effect of Fusidic Acid.

Authors:  Nihan Şık; Kevser Asena Çakan Başerdem; Şefika Akyol; Özlem Tüfekçi; Durgül Yılmaz; Murat Duman
Journal:  Turk Arch Pediatr       Date:  2021-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.